|
Department of Health and Human Services (DHHS) Health Care Personnel Influenza Vaccination Interagency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
CC
|
This committee is charged with developing strategies to increase the number of healthcare professionals who are vaccinated with the influenza vaccine.
|
|
Department of Health and Human Services (DHHS) Healthcare Infection Control Practices Advisory Committee (HICPAC)
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
CC
|
This committee serves as the major policy advisory committee in the nation for healthcare epidemiology.
|
|
Department of Health and Human Services (DHHS) Medical Claims Review Panel
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
CC
|
The Medical Claims Review Panel (MCRP) assists the Department of Health and Human Services (DHHS) in meeting its responsibility to provide quality health care in its facilities and by its practitioners. The MCRP reviews paid claims against DHHS facilities and providers to determine if the care provided met the standard of care and makes quality improvement recommendations to health care facilities and individual providers. The Panel meets monthly and includes two National Institutes Health (NIH) representatives; the current Chair of the Panel is an NIH physician.
|
|
Department of Health and Human Services (DHHS) Steering Committee for the Prevention of Healthcare-Associated Infections
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
CC
|
This steering committee is charged with developing a national action plan for addressing the important problem of healthcare-associated infections.
|
|
Department of Health and Human Services (HHS) Biovigilance Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
CC, NHLBI
|
This committee develops systems for reporting adverse events resulting from blood transfusion or donation.
|
|
Developing Clinical Vocabulary Standards for Public Health Reporting
|
Resource Development
|
CDC
|
NLM
|
This collaboration between the National Library Medicine (NLM) and the Centers for Disease Control and Prevention (CDC) is to develop Logical Observation Identifiers Names and Codes (LOINC) for use in public health reporting, including tumor registry reporting and reportable disease reporting.
|
|
Development and Use of a Non-human Primate Model of Pertussis Disease and Transmission
|
Other
|
FDA
|
NIAID
|
The National Institutes of Health (NIH) has been working with the Food and Drug Administration (FDA) towards the development and use of a non-human primate model of pertussis disease and transmission. The unique model helps to test novel vaccines and to understand host immunity.
|
|
Development of New Approach Methodologies to Reduce Animal Use in Toxicity Testing -SBIR/STTR Town Hall Meeting
|
Meeting/ Workshop
|
FDA
|
NIEHS
|
This webinar-based town hall meeting was presented to facilitate improved communication between New Approach Methodologies (NAMs) method developers, including small business (SBIR/STTR) applicants, developing assays to reduce animal use in toxicity testing, and end-users and regulatory agency staff, providing an opportunity for the assay developers to hear from ICCVAM, agency and industry stakeholders on the desired characteristics and requirements for NAM to meet testing requirements.
|
|
Developmental Considerations of Antifungal Drugs to Address Unmet Medical Need
|
Meeting/ Workshop
|
FDA
|
NIAID
|
A virtual public workshop sponsored by FDA regarding the development of new therapies to address unmet medical need for the treatment of infections due to invasive molds and Candida auris. Discussions will focus on the current state and clinical trial design considerations for developing new therapies for these infections.
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OASH
|
NIDDK
|
The DMICC facilitates cooperation, communication, and collaboration on diabetes among the participating government entities. DMICC meetings, held several times a year, help members identify emerging issues and opportunities and develop ways in which different government components can work together and build upon each other’s expertise and resources. This approach helps ensure that federal diabetes activities are coordinated and not duplicated, as well as stimulates collaborations where appropriate.
|